Identi Healthcare Ltd (TLV: IDNT)
Israel
· Delayed Price · Currency is ILS · Price in ILA162.40
-8.70 (-5.08%)
Nov 14, 2024, 5:24 PM IDT
Identi Healthcare Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 9.98 | 10.05 | 9.46 | 8.08 | 7.1 | 5.55 | Upgrade
|
| Revenue Growth (YoY) | 4.77% | 6.28% | 17.10% | 13.78% | 27.99% | 12.77% | Upgrade
|
| Cost of Revenue | 6.47 | 6.38 | 5.05 | 4.75 | 3.95 | 3.3 | Upgrade
|
| Gross Profit | 3.51 | 3.67 | 4.4 | 3.32 | 3.14 | 2.25 | Upgrade
|
| Selling, General & Admin | 7.1 | 7.25 | 7.45 | 3.14 | 1.25 | 1.75 | Upgrade
|
| Research & Development | 3.52 | 3.43 | 3.71 | 6.18 | 2.35 | 3.65 | Upgrade
|
| Operating Expenses | 10.61 | 10.68 | 11.15 | 9.31 | 3.6 | 5.4 | Upgrade
|
| Operating Income | -7.1 | -7.01 | -6.75 | -5.99 | -0.45 | -3.15 | Upgrade
|
| Interest Expense | -0.14 | -0.12 | -0.09 | -0.08 | -0.11 | -0.09 | Upgrade
|
| Interest & Investment Income | 0.27 | 0.37 | 0.04 | - | 0.01 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0 | 0.17 | -0.04 | -0.01 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.02 | 0.04 | 0.1 | -0.02 | -0.01 | Upgrade
|
| Pretax Income | -6.99 | -6.78 | -6.6 | -6.01 | -0.58 | -3.29 | Upgrade
|
| Income Tax Expense | 0 | - | 0.56 | -0.34 | 0.04 | - | Upgrade
|
| Net Income | -6.99 | -6.78 | -7.15 | -5.67 | -0.62 | -3.29 | Upgrade
|
| Net Income to Common | -6.99 | -6.78 | -7.15 | -5.67 | -0.62 | -3.29 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 13 | 11 | 9 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 13 | 11 | 9 | 9 | Upgrade
|
| Shares Change (YoY) | - | - | 15.17% | 21.59% | - | - | Upgrade
|
| EPS (Basic) | -0.55 | -0.54 | -0.57 | -0.52 | -0.07 | -0.37 | Upgrade
|
| EPS (Diluted) | -0.55 | -0.54 | -0.57 | -0.52 | -0.07 | -0.37 | Upgrade
|
| Free Cash Flow | -4.35 | -6.17 | -6.9 | -3.11 | -0.19 | -0.26 | Upgrade
|
| Free Cash Flow Per Share | -0.35 | -0.49 | -0.55 | -0.28 | -0.02 | -0.03 | Upgrade
|
| Gross Margin | 35.19% | 36.53% | 46.56% | 41.15% | 44.29% | 40.50% | Upgrade
|
| Operating Margin | -71.10% | -69.73% | -71.38% | -74.17% | -6.37% | -56.88% | Upgrade
|
| Profit Margin | -70.04% | -67.43% | -75.63% | -70.23% | -8.74% | -59.39% | Upgrade
|
| Free Cash Flow Margin | -43.59% | -61.38% | -72.98% | -38.56% | -2.73% | -4.72% | Upgrade
|
| EBITDA | -6.91 | -6.92 | -6.68 | -5.74 | -0.3 | -3.14 | Upgrade
|
| EBITDA Margin | -69.17% | -68.83% | -70.61% | -71.06% | -4.28% | -56.59% | Upgrade
|
| D&A For EBITDA | 0.19 | 0.09 | 0.07 | 0.25 | 0.15 | 0.02 | Upgrade
|
| EBIT | -7.1 | -7.01 | -6.75 | -5.99 | -0.45 | -3.15 | Upgrade
|
| EBIT Margin | -71.10% | -69.73% | -71.38% | -74.17% | -6.37% | -56.88% | Upgrade
|
| Advertising Expenses | - | 1.11 | 1.72 | 0.68 | 0.2 | 0.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.